Drug intelligence / Profile preview

macrogol + potassium chloride + sodium chloride + sodium bicarbonate

Development stage
Preclinical
Lead developer
AUG Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Macrogol + potassium chloride + sodium chloride + sodium bicarbonate is an osmotic laxative combination developed by AUG Pharma for the treatment of chronic constipation. The primary active component, macrogol (polyethylene glycol), is a high molecular weight polymer that remains in the gastrointestinal tract, where it binds water molecules through hydrogen bonding. This action increases the osmotic pressure and water content of the stool, leading to softened feces and increased bowel motility through the stimulation of peristalsis. The inclusion of electrolytes (sodium chloride, sodium bicarbonate, and potassium chloride) is intended to maintain isotonicity and prevent the depletion of essential salts or systemic fluid imbalances during the laxative process. This formulation is typically administered as an oral solution prepared from a powder.

Brand names
Macrogol HexalMacrogol HEXAL plus Elektrolyte
Other names
Macrogol with electrolytesPolyethylene glycol with electrolytesPEG with electrolytesMacrogol 3350 with electrolytesMacrogol3350 with electrolytesMacrogol-3350 with electrolytes
02

Targets

Intestinal lumen water / osmotic environment

Beyond the preview

Go deeper on macrogol + potassium chloride + sodium chloride + sodium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on macrogol + potassium chloride + sodium chloride + sodium bicarbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call